These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

407 related articles for article (PubMed ID: 16288117)

  • 21. Genomic footprinting of retinoic acid regulated promoters in embryonal carcinoma cells.
    Dey A; Ozato K
    Methods; 1997 Feb; 11(2):197-204. PubMed ID: 8993032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of all-trans-retinoic acid-mediated L-myc gene regulation in small cell lung cancer.
    Ou X; Campau S; Slusher R; Jasti RK; Mabry M; Kalemkerian GP
    Oncogene; 1996 Nov; 13(9):1893-9. PubMed ID: 8934535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence of epigenetic changes affecting the chromatin state of the retinoic acid receptor beta2 promoter in breast cancer cells.
    Sirchia SM; Ferguson AT; Sironi E; Subramanyan S; Orlandi R; Sukumar S; Sacchi N
    Oncogene; 2000 Mar; 19(12):1556-63. PubMed ID: 10734315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Induction of retinoic acid receptor-beta suppresses cyclooxygenase-2 expression in esophageal cancer cells.
    Li M; Song S; Lippman SM; Zhang XK; Liu X; Lotan R; Xu XC
    Oncogene; 2002 Jan; 21(3):411-8. PubMed ID: 11821953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Specific retinoid receptors cooperate to signal growth suppression and maturation of human embryonal carcinoma cells.
    Spinella MJ; Kitareewan S; Mellado B; Sekula D; Khoo KS; Dmitrovsky E
    Oncogene; 1998 Jul; 16(26):3471-80. PubMed ID: 9692555
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of the laminin beta 1 (LAMB1), retinoic acid receptor beta, and bone morphogenetic protein 2 genes in mutant F9 teratocarcinoma cell lines partially deficient in cyclic AMP-dependent protein kinase activity.
    Shen J; Li C; Gudas LJ
    Cell Growth Differ; 1997 Dec; 8(12):1297-304. PubMed ID: 9419418
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Repression of transforming growth factor-beta receptor type I promoter expression by Sp1 deficiency.
    Periyasamy S; Ammanamanchi S; Tillekeratne MP; Brattain MG
    Oncogene; 2000 Sep; 19(40):4660-7. PubMed ID: 11030155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endogenous reactivation of the RARbeta2 tumor suppressor gene epigenetically silenced in breast cancer.
    Sirchia SM; Ren M; Pili R; Sironi E; Somenzi G; Ghidoni R; Toma S; Nicolò G; Sacchi N
    Cancer Res; 2002 May; 62(9):2455-61. PubMed ID: 11980632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ERbeta sensitizes breast cancer cells to retinoic acid: evidence of transcriptional crosstalk.
    Rousseau C; Nichol JN; Pettersson F; Couture MC; Miller WH
    Mol Cancer Res; 2004 Sep; 2(9):523-31. PubMed ID: 15383631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Retinoic acid upregulates cone arrestin expression in retinoblastoma cells through a Cis element in the distal promoter region.
    Li A; Zhu X; Craft CM
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1375-83. PubMed ID: 11980849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human lung cancer cell lines exhibit resistance to retinoic acid treatment.
    Geradts J; Chen JY; Russell EK; Yankaskas JR; Nieves L; Minna JD
    Cell Growth Differ; 1993 Oct; 4(10):799-809. PubMed ID: 8274449
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carcinogen exposure differentially modulates RAR-beta promoter hypermethylation, an early and frequent event in mouse lung carcinogenesis.
    Vuillemenot BR; Pulling LC; Palmisano WA; Hutt JA; Belinsky SA
    Carcinogenesis; 2004 Apr; 25(4):623-9. PubMed ID: 14656941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retinoic acid causes cell growth arrest and an increase in p27 in F9 wild type but not in F9 retinoic acid receptor beta2 knockout cells.
    Li R; Faria TN; Boehm M; Nabel EG; Gudas LJ
    Exp Cell Res; 2004 Mar; 294(1):290-300. PubMed ID: 14980522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition.
    Chen H; Zhang H; Lee J; Liang X; Wu X; Zhu T; Lo PK; Zhang X; Sukumar S
    Cancer Res; 2007 Sep; 67(17):8007-13. PubMed ID: 17804711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Demethylation in the 5'-flanking region of mouse cellular retinoic acid binding protein-I gene is associated with its high level of expression in mouse embryos and facilitates its induction by retinoic acid in P19 embryonal carcinoma cells.
    Wei LN; Lee CH
    Dev Dyn; 1994 Sep; 201(1):1-10. PubMed ID: 7528580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An EGF receptor inhibitor induces RAR-beta expression in breast and ovarian cancer cells.
    Grunt TW; Puckmair K; Tomek K; Kainz B; Gaiger A
    Biochem Biophys Res Commun; 2005 Apr; 329(4):1253-9. PubMed ID: 15766561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between RAR-beta gene expression defect and its methylation].
    Gao YP; Li M; Zhang YY; Wang H; He XH; Wang ZH
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jul; 42(7):472-6. PubMed ID: 17961338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
    Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
    Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FGF4 dissociates anti-tumorigenic from differentiation signals of retinoic acid in human embryonal carcinomas.
    Maerz WJ; Baselga J; Reuter VE; Mellado B; Myers ML; Bosl GJ; Spinella MJ; Dmitrovsky E
    Oncogene; 1998 Aug; 17(6):761-7. PubMed ID: 9715278
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.